NCT04131426View on ClinicalTrials.gov

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

January 13, 2021

Study Completion Date

April 1, 2022

Conditions
Cachexia; CancerWeight LossLung CancerGastrointestinal Cancer
Interventions
DRUG

Remune

Remune is intended for the dietary management of disease related malnutrition especially in patients with precachexia or cachexia due to cancer or COPD

OTHER

EXCAP©®

EXCAP©® is a home-based low-to-moderate intensity program that employs a tailored walking prescription and total body resistance exercises

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
collaborator

Smartfish AS

INDUSTRY

lead

University of Rochester

OTHER

NCT04131426 - Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia | Biotech Hunter | Biotech Hunter